Friday, July 10, 2026

biotech · HER2 Positive Breast Cancer

Prestige BioPharma

Prestige BioPharma drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Seoul, KR HQ
1 Employees
EMA registrant Type
Company details
Status
Public
HQ
Seoul, KR
Employees
1
Programs
2
Drugs
0
Patents
0
Intelligence · Drug Pipeline

Prestige BioPharma pipeline

Portfolio lens on 0 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

Prestige BioPharma drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

No drugs indexed yet

We have not linked approved or pipeline drugs to this company profile yet.

View clinical projects →